Get the app!
Back to Companies

Veraxa Biotech AG - Post de-SPAC

VRXANasdaqCIK: 0002079109

Veraxa Biotech AG - Post de-SPAC (VRXA) shows 13 recent insider filings from 9 insiders, with all of them on the buy side. With $125.3K in purchases and $0 in sales, the recent tape is heavily weighted toward buying (a net purchase of $125.3K). Baumann Oliver Rolf (Director) is the most active by dollar volume, and the single largest transaction was $75.0K by Baumann Oliver Rolf. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.

Total Volume
$125.3K
Purchases
$125.3K
Sales
$0
Unique Insiders
9

Recent Insider Trades

13 loaded
Oct 29VRXA
Veraxa Biotech AG - Post de-SPAC
Gruninger MarcDirectorBuy$10.0K
Oct 21VRXA
Veraxa Biotech AG - Post de-SPAC
Ziegler Christoph SamuelDirectorBuy$32.7K
Sep 14VRXA
Veraxa Biotech AG - Post de-SPAC
Willener Raju SudirChief Financial OfficerOther$0
Aug 31VRXA
Veraxa Biotech AG - Post de-SPAC
Antz Christoph RudigerChief Executive Officer, DirectorBuy$7.7K
Aug 31VRXA
Veraxa Biotech AG - Post de-SPAC
Baumann Oliver RolfDirectorBuy$75.0K
Aug 20VRXA
Veraxa Biotech AG - Post de-SPAC
von Halem CarlInterim CFOOther$0
Jun 9VRXA
Veraxa Biotech Holding AG
Buergermeister Torsten Georg FriedrichChief Financial OfficerOther$0
Jun 9VRXA
Veraxa Biotech Holding AG
Schwer HeinzChief Business OfficerOther$0
Jun 10VRXA
Veraxa Biotech Holding AG
Gruninger MarcDirectorOther$0
Jun 9VRXA
Veraxa Biotech Holding AG
Hosseinion WarrenDirectorOther$0
Jun 9VRXA
Veraxa Biotech Holding AG
Antz Christoph RudigerChief Executive Officer, DirectorOther$0
Jun 9VRXA
Veraxa Biotech Holding AG
Baumann Oliver RolfDirectorOther$0
Jun 10VRXA
Veraxa Biotech Holding AG
Ziegler Christoph SamuelDirectorOther$0

13 filings